Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIBOH: Botulinum Toxin for Hypercontractile Esophageal Motility Disorders
NCT01955174Phase 2Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Aug 2013
- Primary completion
- May 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in Hypercontractile esophagus (HE), sponsored by Hospices Civils de Lyon. Started Aug 2013; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Hypercontractile esophagus (HE)
Beyond the preview
Go deeper on NCT01955174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01955174.